Male genital lichen sclerosus and tacrolimus.
Bunker
C B
CB
D000287:Administration, Topical; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D002944:Circumcision, Male; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018459:Lichen Sclerosus et Atrophicus / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D052801:Male Urogenital Diseases / Q000188:drug therapy* / Q000473:pathology; D010412:Penile Neoplasms / Q000139:chemically induced; D016559:Tacrolimus / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D016559:Tacrolimus